Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.
作者： Patrick Gladding , Laura Panattoni , Mark Webster , Leslie Cho , Stephen Ellis
DOI: 10.1016/J.JCIN.2010.08.012
关键词:
摘要: Clopidogrel pharmacogenomics has received significant attention since a black box warning was announced by the Food and Drug Administration in March. This left clinicians difficult situation where many questions remain unanswered. In this brief viewpoint article, we ask some pointed of our own outline pathway that needs to be taken for clinical translation occur.
elsevier.com
onlinejacc.org 参考文章(37)
Paul A. Gurbel, Udaya S. Tantry, Alan R. Shuldiner, Dean J. Kereiakes, Genotyping : One Piece of the Puzzle to Personalize Antiplatelet Therapy Journal of the American College of Cardiology. ,vol. 56, pp. 112- 116 ,(2010) , 10.1016/J.JACC.2010.04.008
Nuala A. Helsby, Pheno- or genotype for the CYP2C19 drug metabolism polymorphism: the influence of disease. Proceedings of the Western Pharmacology Society. ,vol. 51, pp. 5- 10 ,(2008)
Young-Hoon Jeong, Seung-Whan Lee, Bong-Ryong Choi, In-Suk Kim, Myung-Ki Seo, Choong Hwan Kwak, Jin-Yong Hwang, Seong-Wook Park, Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity Results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) Randomized Study Journal of the American College of Cardiology. ,vol. 53, pp. 1101- 1109 ,(2009) , 10.1016/J.JACC.2008.12.025
Patrick Gladding, Harvey White, Jamie Voss, John Ormiston, Jim Stewart, Peter Ruygrok, Badi Bvaldivia, Ruth Baak, Catherine White, Mark Webster, Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. Jacc-cardiovascular Interventions. ,vol. 2, pp. 1095- 1101 ,(2009) , 10.1016/J.JCIN.2009.08.018
Dirk Sibbing, Steven R. Steinhubl, Stefanie Schulz, Albert Schömig, Adnan Kastrati, Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. Journal of the American College of Cardiology. ,vol. 56, pp. 317- 318 ,(2010) , 10.1016/J.JACC.2010.03.048
Thomas Cuisset, Corinne Frere, Jacques Quilici, Pierre-Emmanuel Morange, Jean-Philippe Mouret, Laurent Bali, Pierre-Julien Moro, Marc Lambert, Marie-Christine Alessi, Jean Louis Bonnet, Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders JACC: Cardiovascular Interventions. ,vol. 1, pp. 649- 653 ,(2008) , 10.1016/J.JCIN.2008.08.018
Jean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, Ana Pena, Anne Bellemain-Appaix, Olivier Barthélémy, Guillaume Cayla, Farzin Beygui, Gilles Montalescot, Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis Journal of the American College of Cardiology. ,vol. 56, pp. 134- 143 ,(2010) , 10.1016/J.JACC.2009.12.071
Laurent Bonello, Laurence Camoin-Jau, Stéphane Arques, Christian Boyer, Dimitri Panagides, Olivier Wittenberg, Marie-Claude Simeoni, Paul Barragan, Françoise Dignat-George, Franck Paganelli, Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance A Multicenter Randomized Prospective Study Journal of the American College of Cardiology. ,vol. 51, pp. 1404- 1411 ,(2008) , 10.1016/J.JACC.2007.12.044
NA Helsby, Wing Yee Lo, K Sharples, G Riley, M Murray, K Spells, M Dzhelai, A Simpson, Michael Findlay, None, CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype British Journal of Cancer. ,vol. 99, pp. 1251- 1255 ,(2008) , 10.1038/SJ.BJC.6604699
P. FONTANA, J.-S. HULOT, P. DE MOERLOOSE, P. GAUSSEM, Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects. Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 2153- 2155 ,(2007) , 10.1111/J.1538-7836.2007.02722.X